Blog
Posted on 25.05.2020
Horizon Europe: 6 priorities for health Research & Innovation
What key health questions should EU Research & Innovation (R&I) funding aim to address? The Horizon Europe (2021-2027) Health Cluster has provided an answer – well, six answers – which will shape R&I for most of the coming decade. This will also drive my own work in leading the R&I Partnership Policy of MedTech Europe.
Posted on 25.05.2020
Closing the innovation loop: how start-ups can show value
One of my great frustrations is to see start-ups fall at the final hurdle. Too many early-stage companies with promising innovations spend their energy – and funds – answering crucial questions about the safety and effectiveness of their products, only to find that they have no answers to the additional questions asked by payers.
Posted on 07.04.2020
Horizon Europe: 6 priorities for health Research & Innovation
What key health questions should EU Research & Innovation (R&I) funding aim to address? The Horizon Europe (2021-2027) Health Cluster has provided an answer – well, six answers – which will shape R&I for most of the coming decade. This will also drive my own work in leading the R&I Partnership Policy of MedTech Europe.
Posted on 02.03.2020
Can procurement unlock value-based healthcare?
In recent years, there has been increasing attention on how we can address the biggest challenges in healthcare: variation in patient outcomes, unsustainable cost increases, and low-value care. As populations age and the rates of chronic diseases rise, we have no choice but to rethink how we get value from healthcare spending.
Posted on 20.01.2020
VBP: The road from unwanted necessity to high impact strategic partner
Public procurement was established as a way of purchasing products that hospitals need. However, this one-dimensional view of procurement is changing very quickly. From humble beginnings as an obscure back-office function, I am pleased to say procurement is fast becoming a high-impact strategic partner for hospitals.
Posted on 05.12.2019
How innovative procurement can improve healthcare outcomes
In healthcare, the traditional role of procurement was to secure the availability of goods and services needed to deliver care. Once this was achieved, procurement moved one step up the ‘pyramid of procurement activities’: negotiating on product prices and discounts, in order to reduce spending on medical devices and consumables.
Posted on 24.09.2019
What do we need in our ‘value-based procurement’ toolbox?
It’s great that value-based procurement is being introduced into the healthcare procurement world, as I truly believe this is the way to tackle the challenges we face in healthcare today. Though, I do wonder whether we really understand the meaning of this approach and how we can use it in a way it contributes to maximum added value in the healthcare system.
Posted on 02.07.2019
Procurement is on a journey to a ‘value-based’ future
In healthcare, there is an emerging sense of urgency that it's time to move. You'll be familiar with the reasons: increasing demand for health care services, rising healthcare expenditure and unwanted outcome variations among healthcare provider organisations have put most European healthcare systems under pressure.
Posted on 02.07.2019
Can procurement deliver the ‘best value’ for money?
To my mind, the overarching challenge of modern healthcare systems is to increase the value and outcomes of care, not just to control costs. As someone keenly interested in procurement, this leads me to question what it all means for how health systems buy the technologies they need.
Posted on 23.11.2018
Value-based procurement: a users’ guide to improving outcomes and delivering efficiencies in the UK
Health systems across the globe are faced with unprecedented challenges. Demand and patient expectations are rising while financial resources are diminishing. To respond to these trends, we need a new approach to how we manage healthcare.
